Navigating the Landscape of Early Access Programs (EAPs)
Strategic partnerships for early drug access: connecting manufacturers and physicians
Early Access Programs/Expanded Access/Compassionate use Program
EAPs and Compassionate use programs deserve the attention of highly qualified professionals who appreciate the significance of these initiatives and understand the urgency these programs require.
Euromed Pharma is set up to support the industry and the single individuals to ensure patient access to medicines from their very early stages of clinical development, through Phase I, II, and III, and once the product is approved in a country but not yet in another.
Name Patients Programs
Name Patients Program (NPP) are being used by an increasing number of pharma companies to ensure access to therapies also for patients from serious life-threatening or rare diseases that cannot take part in a clinical trial or have no treatment options available. Patients who do not qualify for clinical trials can reserve the right to use patient access.
Strategic partnerships for early drug access: connecting manufacturers and physicians
Euromed Pharma’s role in streamlining access to unlicensed medications
Early Access Programs
EAPs, Name Patient, and Compassionate use programs deserve the attention of highly qualified professionals who appreciate the significance of these initiatives and understand the urgency these programs require.
Euromed Pharma is set up to support the industry and the single individuals to ensure patient access to medicines from their very early stages of clinical development, through Phase I, II, and III, and if the product was just approved in a country but not yet in another.
Name Patients Programs
Early access programs, (EAPs) are being used by an increasing number of pharma companies to ensure access to therapies also for patients from serious life-threatening or rare diseases that cannot take part in a clinical trial or have no treatment options available. Patients who do not qualify for clinical trials nor the EAP program can reserve the right to use patient access.
Euromed Pharma's expertise in facilitating patient access to necessary therapies
What we do
Import: Dedicated import procedure activation under our own name
Custom Clearance: on our side
Outbound Supply: Outbound in-transit supply Insurance risk on transport
Direct contact with Doctors and Hospital: Collecting and managing required import documents
Order Management: Customer Service with our client and Hospitals
Communication with Hospital: Pre-alerting system on the in-transit delivery
Accounting Manager: Invoicing and Cash Collection for reimbursed products
Together throughout your drug’s lifecycle
Privacy Policy – Cookie Policy – Whistleblowing – Euromed Pharma a Petrone Group Company®